With the installation of a highly automated ThermoFlexX Catena-WDLS processing system Cyber Graphics is expecting an increase in productivity by up to 15% This will allow the prepress specialist to better face current challenges and accelerate delivery of top quality flexo plates to its large customer base across the US and Canada 1 December 2022 – A leading prepress trade shop established in 1994 Cyber Graphics is the first in North America to invest in the Catena-WDLS Washer The machine was installed this past June and has already more than lived up to expectations we had to go ahead with the decision to buy the Catena-WDLS without seeing it live; instead we experienced its superior technology through videos and saw it operate via conference calls Now it is here and it’s even better than we anticipated,” he said “What has been most impressive about the installation so far is that we were putting production jobs through in a matter of days it takes weeks to implement new processing technology and get it working seamlessly Cyber Graphics has over 120 employees spread over its four locations in Tennessee and Wisconsin Around 70% of customers are in the flexible packaging sector but the company also serves label (20%) and folding carton (10%) converters with high-quality solvent flexo plates End use applications are mainly for the food Cyber Graphics operates four automated plate processing lines which allow printing plates to be shipped out to customers the next day “Just-in-time delivery is crucial for our customers so we rely on a very high level of automation to ensure we have the productivity and the consistency that these converters need to serve their brand owner customers,” said Bourquin “Having that extra speed really helps offset some of the challenges we are currently facing when it comes to getting the plate delivered to the customer.” including operator handling of plates between each of the processes the ThermoFlexX Catena-WDLS is fully automated meaning that after loading a plate into the system no further intervention is required until the fully finished article comes out and our employees love the new system because it is so user-friendly and intuitive to use,” said Bourquin about the feedback from the factory floor “If you’re serving multiple customers around the country automation is paramount for controlling costs quality and waste; it also means your team can focus on value-added tasks instead of minding the machine we don’t need to pull the plate out to inspect it during the process because we know we’re going to get the result we want.” The partnership with XSYS goes back decades with Cyber Graphics relying on the manufacturer’s technology to remain at the forefront of a highly competitive market “We have known the XSYS team for a very long time and we trust their forward-thinking mentality and their responsiveness Thanks to XSYS innovation and their can-do attitude we have been the first with many new developments over the years such as LED plate exposure,” stated Bourquin “Now we are the first to leverage the power of the Catena-WDLS.” Despite having researched the Catena-WDLS in great detail the exceptional quality of the processor was still a surprise “The deep knowledge of the platemaking process incorporated into the design of the Catena-WDLS has been truly eye-opening for us We had a major outage in 2019 when a machine broke down for 11 days but the ThermoFlexX ProServeX cloud-based monitoring service will prevent such incidents in the future and that’s incredibly reassuring – we definitely made the right call!” Download Word (docx)Download PDF (PDF) XSYS is the specialist for the global flexographic printing industry know-how and our worldwide service network we support our customers in the printing and the packaging industry All our commitment and developments have one goal: brilliant results First we stand for brilliant products that provide our customers with high-quality printing results we ensure the efficient use of resources and thus successful business We exist to bring more brilliance into the packaging industry – into the lives of our customers For brilliant print  results and business success We believe that the world needs brilliance Brilliant ideas and developments to meet the challenges of the future Brilliant people who have the courage and the will to do the right thing Go back Mail: contact@printerslounge.com Imprint | Privacy Policy General Terms of UsePublication service | Job Advertisements       Only anonymized personal data is processed There is no exchange with other servers or clouds Further information regarding the collected data can be found here Protects against cross-site request forgery attacks 25 January 2023 – Common quality issues associated with washout solvents in flexo plate making is the topic of a new technical paper by XSYS The insightful guide which is entitled “XSYS WASHOUT SOLVENTS 101 – How can washout solvents contribute to consistent plate quality?” examines some of the often-heard myths surrounding the washout process and explains the adverse effects the incorrect use of washout solvents can have on the final print quality The guide highlights the importance of maintaining the right balance of components in the special type of solvent the effectiveness of the washout is compromised and numerous issues with the print quality can occur As well as providing solutions to some of these common problems the new guide also explains the history of nylosolv® which was the first chlorine-free washout solvent on the market and the science behind each of its components “We are always keen to share the vast pool of knowledge we have amassed here at XSYS to help our customers maximize productivity “This new technical guide is another great example of how XSYS as a leading supplier to the flexo industry but also delivers more value so our customers can produce brilliant results not only does correctly adjusted washout solvent ensure that the best plate quality is produced it also helps to increase equipment efficiency and longevity which will result in significant cost savings higher productivity and more sustainable production,” said Stephan Reis The XSYS WASHOUT SOLVENTS 101 guide is freely available in multiple languages and can be downloaded here Download Word (.docx)Download PDF (.pdf) I’d never have taken this pill,” says Felicitas Rohrer who is suing German pharmaceuticals giant Bayer claiming its oral contraceptive Yasminelle caused her to suffer a pulmonary embolism The accusations against Bayer’s contraceptive pills Yasminelle and Yaz are not new and the company has already paid out nearly two billion dollars (1,8 billion euros) to around 10 000 women in out-of-court settlements in the United States to avoid long and costly trials Rohrer is suing the company for 200 000 euros (US$220 000) in damages and interest But “the money cannot compensate for what I and other women have gone through,” she told AFP and following a pulmonary embolism – a blockage of the lung’s main artery – Rohrer now has to take an anti-coagulant that significantly reduces her chances of having a baby She suffers from shortness of breath and is forced to wear anti-embolism compression stockings on car journeys of any length She studied to become a vet but now works as a journalist because she is not allowed to carry any heavy loads up to then a perfectly healthy young woman doctors found massive blood clots clogging her heart “The doctors couldn’t believe that a 25-year-old woman could suffer from a pulmonary embolism,” she said And the doctors clearly pointed the finger at the pill The self-help group Rohrer has since set up has collected testimony from around 250 women who suffered similar side effects She is the first person in Germany to sue Bayer over the drug accusing the company of not informing patients sufficiently about the risks associated with Yasminelle The trial opens on Thursday in a court in Waldshut-Tiengen near the Swiss border Bayer – which sold 768 million euros worth of the Yasmin group of contraceptive pills in 2014 compared with total overall group sales of 42 billion euros – rejects the accusations as “unjustified” It insists the pills have a “positive” risk-benefit profile and are approved by every national drug agency notably in a case brought against Bayer in Switzerland copyright in the content of this website vest in The Free Press of Namibia (Proprietary) Limited (Registration No 85/058) The unauthorized making of copies or use of this material constitutes a copyright infringment under the Namibian Copyright and Neighbouring Rights Protection Act Powered by PageSuite © 2025 The Namibian This site asks for consent to use your data We use cookies to enhance your browsing experience We use cookies to help you navigate efficiently and perform certain functions You will find detailed information about all cookies under each consent category below The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site We also use third-party cookies that help us analyze how you use this website and provide the content and advertisements that are relevant to you These cookies will only be stored in your browser with your prior consent You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience Necessary cookies are required to enable the basic features of this site such as providing secure log-in or adjusting your consent preferences These cookies do not store any personally identifiable data Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms Analytical cookies are used to understand how visitors interact with the website These cookies help provide information on metrics such as the number of visitors Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns